Synopsys and Ansys Provide Update Regarding Expected Timing of Acquisition Close
Synopsys (NASDAQ: SNPS) and Ansys (NASDAQ: ANSS) provided an update on their pending acquisition's regulatory approval status. The companies have successfully obtained merger clearance in all jurisdictions except China, where they are in advanced discussions with the State Administration for Market Regulation (SAMR).
The companies emphasized that the merger approvals received so far were based on the transaction's merits and its expected benefits for stakeholders and future technology innovation. They continue to work collaboratively with Chinese regulators to secure the final necessary approval.
Synopsys (NASDAQ: SNPS) e Ansys (NASDAQ: ANSS) hanno fornito un aggiornamento sullo stato dell'approvazione normativa della loro acquisizione in sospeso. Le società hanno ottenuto con successo l'autorizzazione alla fusione in tutte le giurisdizioni tranne che in Cina, dove sono in trattative avanzate con la State Administration for Market Regulation (SAMR).
Le aziende hanno sottolineato che le approvazioni per la fusione finora ottenute si basano sui meriti della transazione e sui benefici attesi per gli stakeholder e l'innovazione tecnologica futura. Continuano a collaborare con le autorità di regolamentazione cinesi per ottenere l'approvazione finale necessaria.
Synopsys (NASDAQ: SNPS) y Ansys (NASDAQ: ANSS) proporcionaron una actualización sobre el estado de la aprobación regulatoria de su adquisición pendiente. Las compañías han obtenido con éxito la autorización para la fusión en todas las jurisdicciones excepto en China, donde están en conversaciones avanzadas con la Administración Estatal para la Regulación del Mercado (SAMR).
Las empresas enfatizaron que las aprobaciones de la fusión recibidas hasta ahora se basan en los méritos de la transacción y sus beneficios esperados para las partes interesadas y la futura innovación tecnológica. Continúan trabajando de manera colaborativa con los reguladores chinos para asegurar la aprobación final necesaria.
Synopsys (NASDAQ: SNPS)와 Ansys (NASDAQ: ANSS)는 진행 중인 인수의 규제 승인 현황에 대한 업데이트를 제공했습니다. 두 회사는 중국을 제외한 모든 관할 구역에서 합병 승인을 성공적으로 획득했으며, 중국에서는 국가시장감독관리총국(SAMR)과 심도 있는 협의를 진행 중입니다.
양사는 지금까지 받은 합병 승인이 거래의 타당성과 이해관계자 및 미래 기술 혁신에 대한 예상 이익을 기반으로 했음을 강조했습니다. 또한 최종 필요한 승인을 확보하기 위해 중국 규제 당국과 계속 협력하고 있습니다.
Synopsys (NASDAQ : SNPS) et Ansys (NASDAQ : ANSS) ont fourni une mise à jour sur le statut de l'approbation réglementaire de leur acquisition en attente. Les entreprises ont obtenu avec succès l'autorisation de fusion dans toutes les juridictions sauf en Chine, où elles sont en discussions avancées avec l'Administration d'État pour la Régulation du Marché (SAMR).
Les sociétés ont souligné que les approbations de fusion reçues jusqu'à présent étaient basées sur les mérites de la transaction et ses bénéfices attendus pour les parties prenantes ainsi que pour l'innovation technologique future. Elles continuent de collaborer étroitement avec les régulateurs chinois pour obtenir l'approbation finale nécessaire.
Synopsys (NASDAQ: SNPS) und Ansys (NASDAQ: ANSS) haben ein Update zum Stand der behördlichen Genehmigung ihrer ausstehenden Übernahme gegeben. Die Unternehmen haben in allen Rechtsgebieten außer China die Fusionsfreigabe erfolgreich erhalten und führen in China fortgeschrittene Gespräche mit der State Administration for Market Regulation (SAMR).
Die Unternehmen betonten, dass die bisher erhaltenen Fusionsgenehmigungen auf den Vorzügen der Transaktion und den erwarteten Vorteilen für die Stakeholder sowie zukünftige technologische Innovationen basieren. Sie arbeiten weiterhin eng mit den chinesischen Regulierungsbehörden zusammen, um die endgültige erforderliche Genehmigung zu erhalten.
- Merger clearance already obtained in all jurisdictions except China
- Advanced stage reached in obtaining final regulatory approval from China
- Transaction recognized for significant benefits to stakeholders and technology innovation
- Final regulatory approval from China still pending
- Timeline for completion remains uncertain pending Chinese regulatory decision
SUNNYVALE, Calif. and
We have already received merger clearance in every jurisdiction other than
About Synopsys
Catalyzing the era of pervasive intelligence, Synopsys, Inc. (Nasdaq: SNPS) delivers trusted and comprehensive silicon to systems design solutions, from electronic design automation to silicon IP and system verification and validation. We partner closely with semiconductor and systems customers across a wide range of industries to maximize their R&D capability and productivity, powering innovation today that ignites the ingenuity of tomorrow. Learn more at www.synopsys.com.
About Ansys
Our Mission: Powering Innovation that Drives Human Advancement™
When visionary companies need to know how their world-changing ideas will perform, they close the gap between design and reality with Ansys simulation. For more than 50 years, Ansys software has enabled innovators across industries to push boundaries by using the predictive power of simulation. From sustainable transportation to advanced semiconductors, from satellite systems to life-saving medical devices, the next great leaps in human advancement will be powered by Ansys.
© 2025 Synopsys, Inc. All rights reserved. Synopsys, the Synopsys logo, and other Synopsys trademarks are available at https://www.synopsys.com/company/legal/trademarks-brands.html. Other company or product names may be trademarks of their respective owners.
INVESTOR CONTACT:
Trey Campbell
Synopsys, Inc.
650-584-4289
Synopsys-ir@synopsys.com
Kelsey DeBriyn
ANSYS, Inc.
724-820-3927
kelsey.debriyn@ansys.com
EDITORIAL CONTACTS:
Cara Walker
Synopsys, Inc.
650-584-5000
corp-pr@synopsys.com
Mary Kate Joyce
ANSYS, Inc.
724-820-4368
MaryKate.Joyce@ansys.com
Cautionary Statement Regarding Forward-Looking Statements
This communication may contain certain forward-looking statements within the meaning of the federal securities laws with respect to the proposed transaction between Synopsys and Ansys, including, but not limited to, statements regarding the anticipated timing of the closing thereof and the regulatory approvals required for completion of the proposed transaction. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions or the negatives of these words or other comparable terminology to convey uncertainty of future events or outcomes.
Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks, uncertainties and other factors that could cause actual future events to differ materially from the forward-looking statements in this communication, including, but not limited to: (i) the completion of the proposed transaction on anticipated terms and timing, (ii) the failure to satisfy the conditions to the consummation of the proposed transaction, including the receipt of certain governmental and regulatory approvals on the terms expected, in a timely manner, or at all, (iii) the risk that such regulatory approvals may result in the imposition of conditions that could adversely affect, following completion of the proposed transaction (if completed), the combined company or the expected benefits of the proposed transaction, (iv) the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement, (v) the effect of the pendency of the proposed transaction on Ansys' or Synopsys' business relationships, competition, business, financial condition, and operating results, (vi) risks that the proposed transaction disrupts current plans and operations of Ansys or Synopsys and the ability of Ansys or Synopsys to retain and hire key personnel, (vii) risks related to diverting either management team's attention from ongoing business operations of Ansys or Synopsys, (viii) the outcome of any legal proceedings that may be instituted against Ansys or Synopsys related to the merger agreement or the proposed transaction, (ix) the ability of Synopsys to successfully integrate Ansys' operations and product lines, (x) the ability of Synopsys to implement its plans, forecasts, expected financial performance and other expectations with respect to Ansys' business or the combined business after the completion of the proposed transaction and realize the benefits expected from the proposed transaction (if completed), as well as manage the scope and size of the combined company, (xi) risks associated with third party contracts containing consent and/or other provisions that may be triggered by the proposed transaction, (xii) uncertainty in the macroeconomic and geopolitical environment and its potential impact on the semiconductor and electronics industries, (xiii) uncertainty in the growth of the semiconductor, electronics and artificial intelligence industries, (xiv) the highly competitive industries in which Synopsys and Ansys operate, (xv) actions by the
These risks, uncertainties and factors, as well as other risks associated with the proposed transaction, are more fully discussed in the proxy statement/prospectus filed with the SEC in connection with the proposed transaction. While the list of risks, uncertainties and factors presented here, and the list of risks presented in the proxy statement/prospectus, are considered representative, no such list is exhaustive. Unlisted risks, uncertainties and factors may present significant additional obstacles to the realization of forward-looking statements.
You should carefully consider the foregoing factors and the other risks and uncertainties that affect the businesses of Synopsys and Ansys described in the "Risk Factors" section of their respective Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other documents filed by either of them from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond Synopsys' and Ansys' control, and are not guarantees of future results. Readers are cautioned not to put undue reliance on forward-looking statements, and Synopsys and Ansys assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law. Neither Synopsys nor Ansys gives any assurance that either Synopsys or Ansys will achieve its expectations.
View original content to download multimedia:https://www.prnewswire.com/news-releases/synopsys-and-ansys-provide-update-regarding-expected-timing-of-acquisition-close-302494394.html
SOURCE Synopsys, Inc.
FAQ
What is the current status of Synopsys' acquisition of Ansys?
Which regulatory approvals are still pending for the Synopsys-Ansys merger?
How many regulatory approvals has Synopsys received for the Ansys acquisition?
What benefits are expected from the Synopsys-Ansys merger?
What is the timeline for completing the Synopsys-Ansys merger?
